Linezolid pharmacokinetics and pharmacodynamics in clinical treatment

MS Dryden - Journal of antimicrobial chemotherapy, 2011 - academic.oup.com
Linezolid has been widely used in the treatment of Gram-positive infections for more than a
decade. It is unique amongst antibiotics active against most multiply-resistant Gram-positive …

Linezolid: safety and efficacy in special populations

FK Gould - Journal of antimicrobial chemotherapy, 2011 - academic.oup.com
Linezolid has been in general use in the UK since 2000. Although toxicity, particularly
haematological and neurological, has been an issue, linezolid has proved to be an effective …

Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE

JB Bossaer, PD Hall, E Garrett-Mayer - Supportive Care in Cancer, 2011 - Springer
Purpose This study seeks to determine the incidence of vancomycin-resistant enterococci
(VRE) infection in high-risk neutropenic fever patients colonized with VRE and to determine …

[HTML][HTML] Bloodstream infections and mortality-related factors in febrile neutropenic cancer patients

ES Horasan, G Ersoz, A Tombak, N Tiftik… - … medical journal of …, 2011 - ncbi.nlm.nih.gov
Bloodstream infections and mortality-related factors in febrile neutropenic cancer patients -
PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …

Outcomes of therapy: vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients

S Kraft, E Mackler, P Schlickman, K Welch… - Supportive Care in …, 2011 - Springer
Purpose The purpose of this study was to evaluate the risk factors associated with the
treatment failure and 30-day mortality in hematology and bone marrow transplant patients …

[HTML][HTML] Farmacocinética y farmacodinamia de antimicrobianos: a propósito de pacientes con neutropenia y fiebre

JR Garzón, S Cuervo, J Gómez… - Revista chilena de …, 2011 - SciELO Chile
La neutropenia febril es una complicación grave de la terapia antineoplásica que se
presenta más frecuentemente en pacientes con neoplasias hematológicas, asociada a …

Antibacterial distribution and drug–drug interactions in cancer patients

U Theuretzbacher, M Zeitlinger - Principles and practice of cancer …, 2011 - Springer
Cancer as such does not impact distribution of antimicrobials; however, various
pathophysiological changes in cancer patients may do so. Neutropenia, cachexia …